Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G‐CSF

Background and Objectives Biosimilars of the granulocyte colony stimulating factor (G?CSF) filgrastim were approved by the European Medicines Agency (EMA) for registered indications of the originator G?CSF, including prevention and treatment of neutropenia, as well as mobilization of peripheral bloo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schmitt, Michael (VerfasserIn) , Hoffmann, Jean-Marc (VerfasserIn) , Lorenz, Katrin (VerfasserIn) , Schmitt, Anita (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 8 March 2016
In: Vox sanguinis
Year: 2016, Jahrgang: 111, Heft: 2, Pages: 178-186
ISSN:1423-0410
DOI:10.1111/vox.12397
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1111/vox.12397
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/vox.12397
Volltext
Verfasserangaben:Schmitt M., Hoffmann J.‐M., Lorenz K., Publicover A., Schmitt A., Nagler A.

MARC

LEADER 00000caa a2200000 c 4500
001 1571537724
003 DE-627
005 20230428184858.0
007 cr uuu---uuuuu
008 180329s2016 xx |||||o 00| ||eng c
024 7 |a 10.1111/vox.12397  |2 doi 
035 |a (DE-627)1571537724 
035 |a (DE-576)501537724 
035 |a (DE-599)BSZ501537724 
035 |a (OCoLC)1341001129 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
245 1 0 |a Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G‐CSF  |c Schmitt M., Hoffmann J.‐M., Lorenz K., Publicover A., Schmitt A., Nagler A. 
264 1 |c 8 March 2016 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.03.2018 
520 |a Background and Objectives Biosimilars of the granulocyte colony stimulating factor (G?CSF) filgrastim were approved by the European Medicines Agency (EMA) for registered indications of the originator G?CSF, including prevention and treatment of neutropenia, as well as mobilization of peripheral blood stem cells in 2008. Nevertheless, there is still an ongoing debate regarding the quality, efficacy and safety of biosimilar G?CSF. Materials and Methods This article is a meta?analysis of clinical studies on the use of biosimilar G?CSF for mobilization and transplantation of haematopoietic stem cells as available in public databases. All data sets were weighted for the number of patients and parameters and then subjected to statistical meta?analysis employing the Mann?Whitney U?test followed by the Hodges?Lehmann estimator to assess differences between biosimilar and originator G?SCF. Results A total of 1892 individuals, mostly with haematological malignancies but also including 351 healthy donors have been successfully mobilized for autologous or allogeneic stem cell transplantation using biosimilar G?CSF (ZarzioTM: 1239 individuals; RatiograstimTM/TevagrastimTM: 653 individuals). A total of 740 patients with multiple myeloma, 491 with non?Hodgkin's lymphoma (NHL), 150 with Hodgkin's lymphoma (HL) and other diseases are included in this meta?analysis, as well as 161 siblings and 190 volunteer unrelated donors. For biosimilar and originator G?CSF, bioequivalence was observed for the yield of CD34+ stem cells as well as for the engraftment of the transplants. Conclusion Biosimilar G?CSF has equivalent effects and safety as originator G?CSF. 
650 4 |a autologous & allogeneic transplantation 
650 4 |a biosimilar G‐CSF 
650 4 |a haematopoietic stem cells 
650 4 |a healthy donors 
650 4 |a mobilization 
700 1 |a Hoffmann, Jean-Marc  |d 1992-  |e VerfasserIn  |0 (DE-588)1147869278  |0 (DE-627)1007274328  |0 (DE-576)496081381  |4 aut 
700 1 |a Lorenz, Katrin  |d 1988-  |e VerfasserIn  |0 (DE-588)1066501777  |0 (DE-627)817656715  |0 (DE-576)426016823  |4 aut 
700 1 |a Schmitt, Anita  |d 1969-  |e VerfasserIn  |0 (DE-588)141722495  |0 (DE-627)630587752  |0 (DE-576)325593892  |4 aut 
773 0 8 |i Enthalten in  |t Vox sanguinis  |d Oxford [u.a.] : Wiley-Blackwell, 1956  |g 111(2016), 2, Seite 178-186  |h Online-Ressource  |w (DE-627)300897936  |w (DE-600)1483587-3  |w (DE-576)09440402X  |x 1423-0410  |7 nnas  |a Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G‐CSF 
773 1 8 |g volume:111  |g year:2016  |g number:2  |g pages:178-186  |g extent:9  |a Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G‐CSF 
856 4 0 |u http://dx.doi.org/10.1111/vox.12397  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/vox.12397  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180329 
993 |a Article 
994 |a 2016 
998 |g 141722495  |a Schmitt, Anita  |m 141722495:Schmitt, Anita  |d 910000  |d 910100  |e 910000PS141722495  |e 910100PS141722495  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1066501777  |a Lorenz, Katrin  |m 1066501777:Lorenz, Katrin  |d 910000  |d 910100  |e 910000PL1066501777  |e 910100PL1066501777  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1147869278  |a Hoffmann, Jean-Marc  |m 1147869278:Hoffmann, Jean-Marc  |d 910000  |d 910100  |e 910000PH1147869278  |e 910100PH1147869278  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1571537724  |e 3004488167 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Schmitt M., Hoffmann J.‐M., Lorenz K., Publicover A., Schmitt A., Nagler A."]},"id":{"eki":["1571537724"],"doi":["10.1111/vox.12397"]},"relHost":[{"corporate":[{"display":"International Society of Blood Transfusion","role":"isb"}],"pubHistory":["N.S. 1.1956 -"],"name":{"displayForm":["ed.-in-chief M. Contreras"]},"part":{"volume":"111","year":"2016","extent":"9","text":"111(2016), 2, Seite 178-186","issue":"2","pages":"178-186"},"id":{"zdb":["1483587-3"],"doi":["10.1111/(ISSN)1423-0410"],"issn":["1423-0410"],"eki":["300897936"]},"origin":[{"publisher":"Wiley-Blackwell ; Karger ; Blackwell Science ; Blackwell","publisherPlace":"Oxford [u.a.] ; Basel ; Oxford ; Oxford [u.a.]","dateIssuedKey":"1956","dateIssuedDisp":"1956-"}],"note":["Gesehen am 12.04.2019"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"title":[{"subtitle":"international journal of transfusion medicine ; official journal of the International Society of Blood Transfusion","title":"Vox sanguinis","title_sort":"Vox sanguinis"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"300897936","disp":"Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G‐CSFVox sanguinis"}],"person":[{"role":"aut","given":"Michael","family":"Schmitt","display":"Schmitt, Michael"},{"display":"Hoffmann, Jean-Marc","role":"aut","given":"Jean-Marc","family":"Hoffmann"},{"display":"Lorenz, Katrin","role":"aut","given":"Katrin","family":"Lorenz"},{"given":"Anita","role":"aut","family":"Schmitt","display":"Schmitt, Anita"}],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"8 March 2016"}],"title":[{"title":"Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G‐CSF","title_sort":"Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G‐CSF"}],"note":["Gesehen am 29.03.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1571537724","physDesc":[{"extent":"9 S."}]} 
SRT |a SCHMITTMICMOBILIZATI8201